Arete Wealth Advisors, LLC Seres Therapeutics, Inc. Transaction History
Arete Wealth Advisors, LLC
- $1.31 Billion
- Q1 2025
A detailed history of Arete Wealth Advisors, LLC transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Arete Wealth Advisors, LLC holds 20,900 shares of MCRB stock, worth $303,677. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,900
Previous 20,900
-0.0%
Holding current value
$303,677
Previous $17,000
11.76%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding MCRB
# of Institutions
59Shares Held
38.3MCall Options Held
103KPut Options Held
53K-
Flagship Pioneering Inc. Cambridge, MA23.1MShares$336 Million6.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.09MShares$88.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.76MShares$25.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.62MShares$23.5 Million0.0% of portfolio
-
Ubs Group Ag1.46MShares$21.2 Million0.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $1.8B
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...